Evidence map›Paper›PMID 26109086›Full record

ArticleAmerican journal of physiology. Renal physiology2015

MicroRNA-150 deletion in mice protects kidney from myocardial infarction-induced acute kidney injury.

Punithavathi Ranganathan, Calpurnia Jayakumar, Yaoping Tang, Kyoung-mi Park, Jian-peng Teoh, Huabo Su, Jie Li, Il-man Kim, Ganesan Ramesh

Abstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 65 citations in OpenAlex.

  1. Review
  2. Multi-Target Cardioprotection fromAntioxidants (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. MicroRNAs in kidney injury and disease.Nature reviews. Nephrology · 2022
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Epigenetics in kidney diseases.Advances in clinical chemistry · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Punithavathi RanganathanDepartment of Medicine and Vascular Biology Center, Georgia Regents University, Augusta, Georgia.
Calpurnia JayakumarDepartment of Medicine and Vascular Biology Center, Georgia Regents University, Augusta, Georgia.
Yaoping TangDepartment of Medicine and Vascular Biology Center, Georgia Regents University, Augusta, Georgia.
Kyoung-mi ParkDepartment of Medicine and Vascular Biology Center, Georgia Regents University, Augusta, Georgia.
Jian-peng TeohDepartment of Medicine and Vascular Biology Center, Georgia Regents University, Augusta, Georgia.
Huabo SuDepartment of Medicine and Vascular Biology Center, Georgia Regents University, Augusta, Georgia.
Jie LiDepartment of Medicine and Vascular Biology Center, Georgia Regents University, Augusta, Georgia.
Il-man KimDepartment of Medicine and Vascular Biology Center, Georgia Regents University, Augusta, Georgia.
Ganesan RameshDepartment of Medicine and Vascular Biology Center, Georgia Regents University, Augusta, Georgia gramesh@gru.edu.
Augusta University · USGeorgia Regents Medical Center · US

Funding

Neddylation and cardiac protein quality controlR01HL124248 · NHLBI · AUGUSTA UNIVERSITY · PI SU, HUABO · 2014 to 2024
$4.1M
Beta-arrestin signaling and microRNA biogenesis in cardioprotectionR01HL124251 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI KIM, IL-MAN · 2014 to 2018
$1.9M
Netrin-1 Signaling in Ischemia Reperfusion Injury of the KidneyR01DK083379 · NIDDK · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI RAMESH, GANESAN · 2010 to 2014
$1.4M
American Heart Association-American Stroke Association 14SDG18970040NHLBI NIH HHS R01 HL124248NHLBI NIH HHS R01HL124248NHLBI NIH HHS R01 HL124251NIDDK NIH HHS R01 DK083379
6 · The paper itself

Abstract

Despite greater understanding of acute kidney injury (AKI) in animal models, many of the preclinical studies are not translatable. Most of the data were derived from a bilateral renal pedicle clamping model with warm ischemia. However, ischemic injury of the kidney in humans is distinctly different and does not involve clamping of renal vessel. Permanent ligation of the left anterior descending coronary artery model was used to test the role of microRNA (miR)-150 in AKI. Myocardial infarction in this model causes AKI which is similar to human cardiac bypass surgery. Moreover, the time course of serum creatinine and biomarker elevation were also similar to human ischemic injury. Deletion of miR-150 suppressed AKI which was associated with suppression of inflammation and interstitial cell apoptosis. Immunofluorescence staining with endothelial marker and marker of apoptosis suggested that dying cells are mostly endothelial cells with minimal epithelial cell apoptosis in this model. Interestingly, deletion of miR-150 also suppressed interstitial fibrosis. Consistent with protection, miR-150 deletion causes induction of its target gene insulin-like growth factor-1 receptor (IGF-1R) and overexpression of miR-150 in endothelial cells downregulated IGF-1R, suggesting miR-150 may mediate its detrimental effects through suppression of IGF-1R pathways.

Indexed as

Acute Kidney InjuryAnimalsApoptosisCardiopulmonary BypassGene DeletionKidney Function TestsKidney TubulesMiceMice, Inbred C57BLMice, KnockoutMicroRNAsMyocardial InfarctionReceptor, IGF Type 1Reperfusion InjuryMicroRNAsMirn150 microRNA, mouseReceptor, IGF Type 1acute kidney injurybilateral renal pedicle clamping modelmiR-150myocardial infarction

Identifiers

PMID26109086
PMCPMC4572391
OpenAlexW2203566365

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.